H.B. Fuller (NYSE:FUL) Releases FY 2024 Earnings Guidance
H.B. Fuller (NYSE:FUL – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 3.840-3.840 for the period, compared to the consensus earnings per share estimate of 4.160. The company issued revenue guidance of $3.6 billion-$3.6 billion, compared to the consensus revenue estimate of $3.6 billion. […]
More Stories
Sparta Capital (CVE:SAY) Stock Price Down 25% – Time to Sell?
Shares of Sparta Capital Ltd. (CVE:SAY – Get Free Report) fell 25% during trading on Tuesday . The stock traded...
InterDigital (NASDAQ:IDCC) Shares Down 7.4% Following Insider Selling
InterDigital, Inc. (NASDAQ:IDCC – Get Free Report) dropped 7.4% during trading on Tuesday after an insider sold shares in the...
Kang Jyh Lee Sells 10,000 Shares of Photronics, Inc. (NASDAQ:PLAB) Stock
Photronics, Inc. (NASDAQ:PLAB – Get Free Report) CEO Kang Jyh Lee sold 10,000 shares of the stock in a transaction...
Northern Graphite (CVE:NGC) Trading 25% Higher – Here’s What Happened
Northern Graphite Co. (CVE:NGC – Get Free Report)’s stock price traded up 25% during mid-day trading on Tuesday . The...
One Wealth Capital Management LLC Takes $2.83 Million Position in Broadcom Inc. (NASDAQ:AVGO)
One Wealth Capital Management LLC acquired a new position in shares of Broadcom Inc. (NASDAQ:AVGO – Free Report) in the...
Cingulate Completes Final FDA Study for CTx-1301 ADHD Treatment
On January 7, 2025, Cingulate Inc. (NASDAQ:CING) announced the successful completion of its final FDA-required study for CTx-1301 (dexmethylphenidate) aimed...